Published online before print April 6, 2007

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2007.061170v1 170/6/1831    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, Y. Articles by Zhang, C. Search for Related Content PubMed Articles by Cheng, Y. Articles by Zhang, C.

Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.061170

Accepted for publication February 23, 2007.

Article

MicroRNAs Are Aberrantly Expressed in Hypertrophic Heart. Do They Play a Role in Cardiac Hypertrophy?

Yunhui Cheng^*, Ruirui Ji^*, Junming Yue, Jian Yang^*, Xiaojun Liu^*, He Chen^*, David B. Dean^*, and Chunxiang Zhang^*@

From the Cardiovascular Research Laboratory,* Vascular Biology Center and Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee; and the Magee Women's Hospital Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

^@ To whom correspondence should be addressed. E-mail: czhang1{at}utmem.edu.

	Abstract

MicroRNAs (miRNAs) are a recently discovered class of endogenous, small, noncoding RNAs that regulate gene expression. Although miRNAs are highly expressed in the heart, their roles in heart diseases are currently unclear. Using microarray analysis designed to detect the majority of mammalian miRNAs identified thus far, we demonstrated that miRNAs are aberrantly expressed in hypertrophic mouse hearts. The time course of the aberrant miRNA expression was further identified in mouse hearts at 7, 14, and 21 days after aortic banding. Nineteen of the most significantly dysregulated miRNAs were further confirmed by Northern blot and/or real-time polymerase chain reaction, in which miR-21 was striking because of its more than fourfold increase when compared with the sham surgical group. Similar aberrant expression of the most up-regulated miRNA, miR-21, was also found in cultured neonatal hypertrophic cardiomyocytes stimulated by angiotensin II or phenylephrine. Modulating miR-21 expression via antisense-mediated depletion (knockdown) had a significant negative effect on cardiomyocyte hypertrophy. The results suggest that miRNAs are involved in cardiac hypertrophy formation. miRNAs might be a new therapeutic target for cardiovascular diseases involving cardiac hypertrophy such as hypertension, ischemic heart disease, valvular diseases, and endocrine disorders.

This article has been cited by other articles:

				V. Divakaran and D. L. Mann The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure Circ. Res., November 7, 2008; 103(10): 1072 - 1083. [Abstract] [Full Text] [PDF]

				E. van Rooij, W. S. Marshall, and E. N. Olson Toward MicroRNA-Based Therapeutics for Heart Disease: The Sense in Antisense Circ. Res., October 24, 2008; 103(9): 919 - 928. [Abstract] [Full Text] [PDF]

				P. A. da Costa Martins, M. Bourajjaj, M. Gladka, M. Kortland, R. J. van Oort, Y. M. Pinto, J. D. Molkentin, and L. J. De Windt Conditional Dicer Gene Deletion in the Postnatal Myocardium Provokes Spontaneous Cardiac Remodeling Circulation, October 7, 2008; 118(15): 1567 - 1576. [Abstract] [Full Text] [PDF]

				E. van Rooij, L. B. Sutherland, J. E. Thatcher, J. M. DiMaio, R. H. Naseem, W. S. Marshall, J. A. Hill, and E. N. Olson Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis PNAS, September 2, 2008; 105(35): 13027 - 13032. [Abstract] [Full Text] [PDF]

				T. Thum, D. Catalucci, and J. Bauersachs MicroRNAs: novel regulators in cardiac development and disease Cardiovasc Res, September 1, 2008; 79(4): 562 - 570. [Abstract] [Full Text] [PDF]

				B. Yang, Y. Lu, and Z. Wang Control of cardiac excitability by microRNAs Cardiovasc Res, September 1, 2008; 79(4): 571 - 580. [Abstract] [Full Text] [PDF]

				D. Sayed, S. Rane, J. Lypowy, M. He, I.-Y. Chen, H. Vashistha, L. Yan, A. Malhotra, D. Vatner, and M. Abdellatif MicroRNA-21 Targets Sprouty2 and Promotes Cellular Outgrowths Mol. Biol. Cell, August 1, 2008; 19(8): 3272 - 3282. [Abstract] [Full Text] [PDF]

				M. V. G. Latronico, D. Catalucci, and G. Condorelli MicroRNA and cardiac pathologies Physiol Genomics, August 1, 2008; 34(3): 239 - 242. [Abstract] [Full Text] [PDF]

				D. G. Romero, M. W. Plonczynski, C. A. Carvajal, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez Microribonucleic Acid-21 Increases Aldosterone Secretion and Proliferation in H295R Human Adrenocortical Cells Endocrinology, May 1, 2008; 149(5): 2477 - 2483. [Abstract] [Full Text] [PDF]

				C. Zhang MicroRNomics: a newly emerging approach for disease biology Physiol Genomics, April 1, 2008; 33(2): 139 - 147. [Abstract] [Full Text] [PDF]

				M. V.G. Latronico, D. Catalucci, and G. Condorelli Emerging Role of MicroRNAs in Cardiovascular Biology Circ. Res., December 7, 2007; 101(12): 1225 - 1236. [Abstract] [Full Text] [PDF]

				E. van Rooij and E. N. Olson microRNAs put their signatures on the heart Physiol Genomics, November 14, 2007; 31(3): 365 - 366. [Full Text] [PDF]